Prodigy The one thing that is certain is that I will not buy this stock.Initially i thought it was overvalued but had a future.Now I am certain it is a rubbish stock. All hype and no substance.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%